Second Genome
PrivateLast Round
M&A
Jan 2, 2024
Total Funding Raised
$114.36M
Company Overview
Second Genome is a biotechnology company that utilizes a microbiome data platform to extract microbial genetic insights for the development of precision therapies and biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Second Genome Comparables
Compare Second Genome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microbiotica | 78% | |
| Nuanced Health | 78% | |
| Cmbio | 76% | |
Second Genome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jan 2, 2024 | ||||
| Corporate Funding | Apr 6, 2020 | ||||
| Grant | Sep 1, 2019 | ||||
| Grant | Jul 1, 2017 | ||||
| Series B Extension | Jul 13, 2016 | ||||
Series B | Apr 20, 2016 |
Second Genome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series B |
| Digitalis Ventures | Series B, Series B Extension |
| Schroder Adveq | Series B |
| NIH RADx | Grant |
| Wavepoint Ventures | Seed, Series A |
| Lifeforce Capital | Series B |
| Seraph Group | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2024
Completed an M&A funding round.
- Sep 1, 2019
$967K grant received from NIH RADx.
Second Genome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Second Genome's valuation, stock price, and market status.